condition associated with low HDL levels, tissue macrophage foam cell accumulation, and probably with premature atherosclerosis; however, the relationship to cardiovascular disease is controversial. [13] [14] [15] Transplantation of Abca1 −/− bone marrow (BM) into hypercholesterolemic Ldlr −/− recipients resulted in moderately accelerated atherosclerosis, 16 a result which has been widely interpreted as indicating that macrophage ABCA1 deficiency causes accelerated atherosclerosis. However, a direct test of the role of macrophage ABCA1 deficiency in atherosclerosis using LysmCreAbca1 fl/fl Ldlr −/− mice failed to show any difference compared with control Abca1 fl/fl Ldlr −/− mice. 17 One possible explanation for this unexpected result was compensation by alternative cholesterol efflux pathways, notably that mediated by ABCG1. Indeed transplantation of Abca1 −/− Abcg1 −/− BM into Ldlr +/− recipients resulted in markedly accelerated atherosclerosis, compared with Ldlr +/− mice transplanted with Abca1 −/− , Abcg1 −/− , or wild-type BM. 18 However, further studies revealed an underlying expansion and proliferation of hematopoietic stem and multipotential progenitor cells (HSPCs) in Abca1 −/− Abcg1 −/− BM-transplanted Ldlr +/mice, leading to increased production of monocytes and neutrophils. 19 Thus, the antiatherogenic role of cholesterol efflux pathways mediated by transporters in macrophages could not be clearly deduced from the results of this experiment in which Abca1 and Abcg1 were deleted in all BM cells.
To more directly evaluate the role of ABCA1 and ABCG1 in macrophages, we have developed Abcg1 fl/fl mice and crossbred them with LysmCreAbca1 fl/fl mice to generate LysmCreAbca1 fl/ fl Abcg1 fl/fl mice. The goals of our study were to assess effects of macrophage ABCA1 and ABCG1 transporter deficiency on atherosclerosis and plaque inflammation in Ldlr −/− mice, and to compare the effects of macrophage knockout of ABCA1/G1 transporters with general bone marrow deficiency of ABCA1/ G1. While demonstrating a role of macrophage ABCA1/G1 in atherogenesis and plaque inflammation, our findings also uncovered an unexpected role of macrophage foam cells in the spleen in driving monocyte production, with suppression of this process by ABCA1/G1 and high levels of HDL.
Methods
An expanded version of the methods can be found in the online Data Supplement.
Ldlr −/− and Ldlr −/− APOA1TG mice were transplanted with LysmCreAbca1 flox/flox Abcg1 flox/flox (MAC-ABC DKO ) or Abca1 flox/flox Abcg1 flox/flox (control) BM. Ldlr −/− mice were transplanted with Abca1 −/− Abcg1 −/− or wild-type BM or a 1:1 mix of CD45.1 wild-type and CD45.2 control or CD45.2 MAC-ABC DKO BM. All experiments were performed in the B6 background. Five weeks after BM transplantation (BMT), mice were fed either the chow diet for 15 weeks or the Western-type diet (WTD) for 7 to 8 weeks (as indicated). Leukocyte subsets were monitored by flow cytometry, cholesterol levels by enzymatic assays, and monocyte chemoattractant protein 1 (MCP-1), machrophage colony stimulating factor (M-CSF), and granulocyte colony stimulating factor (G-CSF) levels by ELISA. After the indicated period of diet, mice were euthanized and atherosclerotic lesion area was analyzed in the aortic root. MAC-ABC DKO and control macrophages were characterized for cholesterol efflux and inflammatory gene expression. All protocols were approved by the Institutional Animal Care and Use Committee of Columbia University. The Abca1 flox/flox Abcg1 flox/flox mice will be available at the Jackson Laboratory Repository (JAX) with the JAX Stock No. 021067 and can be found at http://jaxmice.jax.org/query.
Results

ABCA1 and ABCG1 Expression in MAC-ABC DKO Mice
We assessed the efficiency of Abca1 and Abcg1 deletion in MAC-ABC DKO macrophages and in BM progenitor populations. ABCA1 and ABCG1 protein expressions were reduced by >95% in thioglycollate-elicited peritoneal macrophages (both P<0.05) ( Figure 1A and 1B). MAC-ABC DKO BM monocytes showed a >80% reduction in Abca1 and Abcg1 mRNA expressions (P<0.05; Figure 1C and 1D). In MAC-ABC DKO neutrophils, there was >50% (P<0.05) reduction of Abca1, while the decrease in Abcg1 was not significant. Importantly, Abca1 and Abcg1 expressions were unchanged in the HSPCs, common myeloid progenitors, and granulocyte macrophage progenitors (GMPs; Figure 1C and 1D). In addition, MAC-ABC DKO mice showed decreased ABCA1 and ABCG1 expressions in macrophage-rich tissues, such as spleen and lung, and decreased ABCG1 expression in the liver, whereas liver ABCA1 expression was not affected (Online Figure IIA) . This is consistent with observations that hepatic ABCG1 is expressed primarily in Kupffer cells, whereas ABCA1 is expressed primarily in hepatocytes. 20 Findings in mice fed the WTD were similar to the chow diet, except that there was also partial reduction of Abca1 and Abcg1 expressions in the GMP population and a >90% reduction of Abca1 and Abcg1 in neutrophils (Online Figure IIB and IIC). The more widespread deletion on the WTD may reflect increased liver X receptorinduced expression of Abca1/g1. These findings are consistent with previous reports on the activity of the LysmCre promoter in different cell types. 21, 22 Thus, the LysmCre promoter caused efficient deletion of Abca1 and Abcg1 in macrophages, partial deletion in monocytes, variable deletion in neutrophils and GMPs depending on diet, and importantly, no deletion in BM stem cells. We refer to the LysmCreAbca1 fl/fl Abcg1 fl/fl mice as MAC-ABC DKO mice, with the caveat that deletion in other cell types may have also contributed to phenotypes.
MAC-ABC DKO Mice Characterization-Chow Diet
Cholesterol efflux to apoA1 and HDL was decreased by 83% and 68% in MAC-ABC DKO thioglycollate-elicited macrophages, respectively (both P<0.0001; Online Figure IIIA Ldlr −/− mice transplanted with Abca1 −/− Abcg1 −/− BM on the WTD. 24 As a consequence, the increase in atherosclerosis in these mice was not significant. 24 In an attempt to exclude a confounding factor of decreased VLDL/LDL cholesterol levels to atherosclerosis, we used the chow diet to assess the role of ABCA1/G1 deficiency in macrophages and total BM in atherosclerosis. Ldlr −/− mice were transplanted with MAC-ABC DKO , Abca1 −/− Abcg1 −/− , or wild-type BM. Five weeks after BM transplantation (BMT), the reconstitution of the BM was >95% (results not shown). Cholesterol levels were in a similar range in all groups of mice (Table) . There were relatively minor differences in the VLDL/LDL fraction (16% decrease in MAC-ABC DKO BM versus control and 18% in Abca1 −/− Abcg1 −/− BM versus wild-type; Online Figure IVA and IVB). In MAC-ABC DKO BM-transplanted Ldlr −/− mice, monocyte levels were similar to controls, whereas neutrophil levels were increased by 50% (P<0.05; Figure 2A ). Notably, BM HSPCs were not affected as compared with controls (Online Figure IVC) . The neutrophilia was likely caused by 50% (P<0.05) increased levels of G-CSF in plasma and 20% (P<0.05) increased G-csf mRNA in the spleen. We observed no differences in plasma M-CSF levels or splenic M-csf mRNA expression Thioglycollate-elicited peritoneal macrophages were isolated, incubated with the liver X receptor activator TO901317 (3 µmol/L, 24 h), and ABCA1 and ABCG1 expressions were assessed by Western blot. Bands were quantified using Image J and corrected for β-actin expression (bar graphs). C and D, Bone marrow cells were sorted into RLT-buffer by fluorescence-activated cell sorting and the mRNA expressions of ABCA1 (C) and ABCG1 (D) were assessed and corrected for the housekeeping gene m36B4. *P<0.05, **P<0.01, ***P<0.001. CMP indicates common myeloid progenitors; GMP, granulocyte macrophage progenitors; and HSPC, hematopoietic stem and multipotential progenitor cells.
(results not shown). MCP-1 plasma levels were increased by 57% (P<0.001) in MAC-ABC DKO BMT Ldlr −/− mice, whereas splenic Mcp-1 mRNA was unchanged (results not shown), suggesting that macrophage-rich tissues other than spleen contributed to the increased MCP-1 levels in plasma. In contrast to MAC-ABC DKO BM-transplanted Ldlr −/− mice, mice transplanted with BM completely deficient in ABCA1/G1, that is, Abca1 −/− Abcg1 −/− BM-transplanted Ldlr −/− mice showed increased monocyte levels (≈52%; P<0.01) with similar increases in both Ly6-C hi and Ly6-C lo monocyte subsets, and neutrophil levels were increased by 2.3-fold (P<0.001; Figure 2B ). This coincided with a 2.9fold BM HSPC expansion (P<0.05; Online Figure IVD ), similar to our previous findings. 19 Twenty weeks after BMT, mice were euthanized and atherogenesis was assessed in the aortic root. Deficiency of ABCA1 and ABCG1 in macrophages increased atherosclerotic lesion area by ≈73% (P<0.05; Figure 2C ). Strikingly, BM ABCA1/G1 deficiency increased atherosclerotic lesion area by 2.7-fold as compared with the control group (P<0.001; Figure 2C ), and by ≈54% compared with macrophage ABCA1/G1 deficiency (P<0.05; Figure 2C ). For further characterization, lesions were classified as macrophage foam cell rich lesions, complex lesions with fibrous caps, and advanced lesions with necrotic cores and cholesterol clefts. Although controls with detectable atherosclerosis mainly showed macrophage foam cell rich lesions, MAC-ABC DKO BM-transplanted Ldlr −/− mice showed an increased number of complex lesions with fibrous caps compared with controls (P<0.01), and Abca1 −/− Abcg1 −/− BM-transplanted Ldlr −/− mice showed more complex and advanced lesions than controls and MAC-ABC DKO BM-transplanted Ldlr −/− mice (both P<0.001; Figure 2D ). Although both MAC-ABC DKO and Abca1 −/− Abcg1 −/− BM-transplanted Ldlr −/− mice showed neutrophilia, we observed only very low numbers of neutrophils in the lesions (1 or 2 per lesion) and no difference between the genotypes (results not shown).
Importantly, the findings provide direct evidence that defective monocyte/macrophage cholesterol efflux leads to accelerated atherosclerosis. Because monocytosis is greater and lesions are larger and more advanced in Abca1 −/− Abcg1 −/− BM-transplanted mice compared with MAC-ABC DKO BMtransplanted mice, these results also suggest a major role of HSPC expansion and monocytosis in accelerating lesions development in mice with complete BM deficiency of ABCA1/G1.
Macrophage ABCA1 and ABCG1 Deficiency Leads to Monocytosis and Neutrophilia in Ldlr −/− Mice on the WTD, With Reversal by Increased HDL
We next investigated the role of macrophage ABCA1 and ABCG1 in monocytosis and atherosclerosis under more hypercholesterolemic conditions and also assessed the effects of increased HDL levels. Ldlr −/− and Ldlr −/− APOA1TG mice were transplanted with MAC-ABC DKO or control BM and fed the WTD. Because Abca1/g1 expression was not reduced in HSPCs (Online Figure IIB and IIC), we anticipated no major increase in blood leukocytes. However, MAC-ABC DKO BM-transplanted Ldlr −/− mice showed increased blood monocyte (2.4-fold) and neutrophil (2.1-fold) levels (both P<0.001), with increases in both Ly6-C lo and Ly6-C hi subsets ( Figure 3 ). Expression of the APOA1TG in MAC-ABC DKO BM-transplanted Ldlr −/− decreased leukocytosis (monocytes, 43%; neutrophils, 30%; both P<0.001). The APOA1TG did not decrease leukocyte levels in control BM-transplanted Ldlr −/− mice ( Figure 3 ). Plasma levels of human apoA1 were similar (251±9 mg/dL, control BM; and 201±23 mg/dL, MAC-ABC DKO BM) in both APOA1TG groups. Thus, feeding the WTD caused MAC-ABC DKO BM-transplanted Ldlr −/− mice to develop monocytosis and exaggerated the neutrophilia seen on the chow diet. Increased HDL levels achieved by expression of the human APOA1TG led to a suppression of these effects.
Increased Monocyte Proliferation in MAC-ABC DKO BM-Transplanted Ldlr −/− Mice on the WTD
We undertook studies to elucidate the mechanisms underlying the unexpected monocytosis observed in MAC-ABC DKO BMtransplanted Ldlr −/− mice on the WTD. 4',6-diamidino-2-phenylindole (DAPI) staining showed a 48% increase (P<0.01) in BM monocytes and ≈10% increase in GMPs (P<0.05) in the G2M phase of the cell cycle, indicating increased BM monocyte and GMP proliferation in MAC-ABC DKO BM-transplanted Ldlr −/− mice (Online Figure VA) . HSPC and common myeloid progenitor proliferation were unchanged (Online Figure VA) . The increased proliferation was associated with ≈40% increase in GMPs in MAC-ABC DKO BM (P<0.05), whereas BM monocyte levels were similar (Online Figure VB and VC) . This suggests that monocytosis was attributable to increased production and more rapid release of monocytes into the circulation.
We have shown that ABCA1/G1 deficiency in HSPCs increased their proliferation, associated with increased membrane cholesterol accumulation, and increased cell surface expression of the IL-3 receptor common β subunit (IL-3Rβ). 19 MAC-ABC DKO BM monocytes showed increased staining of cholera toxin B (≈21%; P<0.05), suggesting increased membrane cholesterol accumulation (results not shown). Surface expression of the IL-3Rβ subunit was modestly increased in MAC-ABC DKO BM monocytes (37%; P<0.01) and GMPs (≈10%; P<0.05; results not shown). Blood MAC-ABC DKO monocytes showed 50% increased lipid accumulation (Online Figure VD and VE) , and the surface expression of the IL-3Rβ was increased by 30% (P<0.05; results not shown), but monocyte proliferation was not increased. We did not find increased monocyte activation in our model as assessed by measuring CD11a, CD11b, CD11c, and VLA4 on monocytes (results not shown). 
Monocytosis and Neutrophilia in MAC-ABC DKO BM-Transplanted Ldlr −/− Mice on the WTD Are Mediated Through a Cell-Extrinsic Mechanism
These observations suggested that monocyte proliferation could be the consequence of ABCA1/G1 deficiency in monocytes, leading to lipid accumulation and increased cell surface IL-3Rβ. This would represent a cell autonomous proliferative effect. To assess this, we performed a competitive BMT. Ldlr −/− mice were transplanted with a 1:1 mix of CD45.1 wildtype plus CD45.2 MAC-ABC DKO BM or a 1:1 mix of CD45.1 wild-type plus CD45.2 control BM. Mice were fed WTD, and monocyte levels were assessed. In line with our previous observations, WTD feeding led to increased blood monocyte levels in CD45.1 wild-type plus CD45.2 MAC-ABC DKO BMtransplanted Ldlr −/− mice, compared with their controls (≈50%; P<0.001; Figure 4A) . Surprisingly, however, the ratio of CD45.2:CD45.1 blood monocytes was unchanged ( Figure 4B ). Therefore, although we observed a cell autonomous increase in BM CD45.2 MAC-ABC DKO monocyte proliferation, this did not lead to an increase in this population in the blood. One possible explanation would be that there was increased turnover of MAC-ABC DKO monocytes attributable to enhanced apoptosis as shown previously for Abca1 −/− Abcg1 −/− macrophages. 25 However, annexin V staining of blood monocytes showed no difference between MAC-ABC DKO and control monocytes (results not shown). We therefore concluded that a cell-extrinsic mechanism primarily contributed to the monocytosis in WTDfed MAC-ABC DKO BM-transplanted Ldlr −/− mice. Similar data were found in neutrophils ( Figure 4C and 4D) . Thus, neutrophilia was also regulated by cell-extrinsic factors.
Increased Expressions of M-CSF and G-CSF in Spleen and Plasma of MAC-ABCDKO BM-Transplanted Ldlr −/− Mice on the WTD
We next investigated the nature of the cell-extrinsic factors contributing to monocytosis and neutrophilia in MAC-ABC DKO BM-transplanted Ldlr −/− mice on the WTD. We found that spleens of MAC-ABC DKO mice on the WTD were enlarged (50%; P<0.001) and showed prominent lipid accumulation (Online Figure VI) . G-csf mRNA was 40% increased in MAC-ABC DKO spleens (P<0.05; Figure 5A ). We Figure 5A ). Isolation of splenic cells showed this was attributable to increased expressions of Mcp-1 and M-csf mRNA in monocytes and macrophages, respectively (P<0.05 and P<0.01; Figure 5B ), together with an increase in these cell populations (P<0.001, monocytes; and P<0.05, macrophages; Figure 5C ). Furthermore, plasma M-CSF levels were increased by 40% (P<0.001) and plasma MCP-1 levels by 95% (P<0.01), and this was reversed by human APOA1TG expression ( Figure 5D (Figure 5F ). Thus the neutrophilia was likely accounted for by increased G-CSF levels.
WTD-fed MAC-ABC DKO BM-transplanted Ldlr −/− mice develop atherosclerosis at low cholesterol levels and show increased inflammatory and chemokine gene expression in atherosclerotic plaques.
Cholesterol levels in MAC-ABC DKO BM-transplanted
Ldlr −/− mice were 534±23 mg/dL, which was 54% decreased (P<0.001) compared with cholesterol levels in control BMtransplanted Ldlr −/− mice (1162±68 mg/dL). The decrease was found in the VLDL/LDL fraction (Online Figure VII) . After 7.5 weeks of Western-type diet, we found similar atherosclerotic lesion areas in Ldlr −/− mice transplanted with control or MAC-ABC DKO BM ( Figure 6A ), despite the decreased VLDL/ LDL cholesterol levels in the latter group. However, the onset of atherogenesis occurred at 46% of the cholesterol level in MAC-ABC DKO BM-transplanted Ldlr −/− mice ( Figure 6B) , and cholesterol levels seemed to correlate with atherosclerotic lesion area only in control BM-transplanted Ldlr −/− mice (r=0.6154; P<0.05; Figure 6B ). Both groups of mice showed mainly macrophage-rich lesions (data not shown).
We then performed laser capture microscopy and assessed the mRNA expression of proatherogenic chemokines in the macrophage population. Interestingly, the cells in lesions from MAC-ABC DKO BM-transplanted Ldlr −/− mice showed increased mRNA expression of Mip-1α (P<0.05; Figure 6C ) and a trend toward increased Mcp-1 mRNA. Both of these chemokines are involved in monocyte recruitment and have been reported to accelerate atherogenesis. 26, 27 The expression level of other inflammatory cytokines was also assessed but no significant increases were found (results not shown), possibly because of the decreased plasma cholesterol levels. As expected, the cells in lesions from MAC-ABC DKO BM-transplanted Ldlr −/− mice completely lacked Abca1 and Abcg1 mRNA expressions (P<0.001 and P<0.05, respectively; Figure 6C ). We also performed laser capture microscopy analysis of samples collected in an earlier study in which Ldlr +/− mice had been transplanted with Abca1 −/− Abcg1 −/− BM and had been fed the Paigen diet for 10 weeks. This analysis of lesional macrophages deficient in ABCA1/G1 also showed increased Mcp-1 and Mip-1α mRNA levels ( Figure 6D ), as well as increased expression of several other inflammatory genes (Il-6, Il-1; results not shown).
Discussion
This study has uncovered several distinct antiatherogenic functions of cholesterol efflux pathways mediated by ABCA1 and ABCG1 (Online Figure VIII) . Our findings suggest that the role of ABCA1/G1 in controlling HSPC proliferation has antiatherogenic consequences (step 1), extending previous observations. The study has also unveiled a positive feedback loop between lipid-laden macrophages in the spleen and BM monocyte and granulocyte production and has shown that this is suppressed by cholesterol efflux via ABC transporters (step 2). Finally, we provide the first direct demonstration of an antiatherogenic effect of the cholesterol efflux pathways in macrophages, acting in lesional macrophages to suppress expressions of chemokines and inflammatory genes, and thus recruitment of monocytes into lesions (step 3). A large body of indirect evidence supports the concept that the antiatherogenic role of HDL is tied to its ability to promote cholesterol efflux from macrophage foam cells. Importantly, measurements of macrophage reverse cholesterol transport, a composite measure of macrophage cholesterol efflux, transport in the bloodstream and excretion into the feces, have shown that a variety of genetic or pharmacological interventions exert parallel effects on macrophage reverse cholesterol transport and atherosclerosis. 28, 29 Moreover, a recent study in humans showed that the capacity of HDL to induce cholesterol efflux from macrophages is a strong inverse predictor of atherosclerotic plaque burden in the coronary or carotid arteries. 30 We now provide direct evidence that macrophage cholesterol efflux pathways mediated by ABCA1 and ABCG1 are antiatherogenic in mice. This was indicated by significantly accelerated atherosclerosis in MAC-ABC DKO BM-transplanted Ldlr −/− mice on a chow diet, when MAC-ABC DKO and control BM-transplanted Ldlr −/− mice had similar moderate elevations of blood cholesterol levels. Even though VLDL/LDL cholesterol levels were reduced by ≈54% in MAC-ABC DKO BM-transplanted Ldlr −/− mice on the WTD, atherosclerosis was similar in both groups, indicating that the expected reduction in lesions resulting from the lower cholesterol levels was counterbalanced by a proatherogenic role of decreased macrophage ABCA1/G1 ( Figure 6C ). For example, lower levels of blood cholesterol may have led to decreased endothelial expression of cell adhesion molecules that recruit monocytes into lesions, offsetting the effects of increased blood monocyte levels. Because LysmCre also deletes floxed genes in neutrophils and monocytes and to some extent in GMPs ( Figure 1C and 1D and Online Figure IIB and IIC), we cannot completely exclude a role of deficiency of cholesterol efflux pathways in these cell types in our results. However, monocytosis and neutrophilia seemed to be driven by cell-extrinsic factors, notably various chemokines, produced by macrophages. Thus, monocytosis and neutrophilia were explained by macrophage transporter deficiency, indicating that defects in macrophage cholesterol efflux pathways were ultimately responsible for disproportionate atherosclerosis in the MAC-ABC DKO group. In contrast to the chow diet, WTD-fed MAC-ABC DKO BMtransplanted Ldlr −/− mice displayed significant monocytosis. Initially, we hypothesized that this unexpected monocytosis was caused by a cell-intrinsic effect in monocytes, reflecting lipid accumulation and increased monocyte proliferation (Online Figure VA , VD, and VE), similar to findings in ABCA1/G1-deficient HSPCs. 19 However, this was disproved by the competitive BMT. Further studies revealed increased chemokine and cytokine expressions in macrophages (Online Figure VIII -step 2) . Thus, M-csf and Mcp-1 mRNA expressions were increased in MAC-ABC DKO peritoneal macrophages and in splenic monocytes/macrophages of WTD-fed MAC-ABC DKO BM-transplanted Ldlr −/− mice ( Figure 5B ). These mice also showed increased plasma MCP-1 and M-CSF ( Figure 5D and 5E). MCP-1 is a ligand for chemokine receptor 2 that mediates the emigration of monocytes out of the BM, 31 whereas M-CSF stimulates monocyte production by GMPs. 32 Findings in the BM showing increased monocyte production and release into the blood are consistent with effects of increased M-CSF and MCP-1. 31, 32 These findings suggest that increased MCP-1 and M-CSF expressions in cholesterol-laden macrophages in the spleen led to monocytosis in MAC-ABC DKO BM-transplanted Ldlr −/− mice on the WTD.
Our studies also suggest a major role of cholesterol efflux pathways in HSPCs in controlling monocytosis and neutrophilia and thus atherosclerosis ( Figure 2C ; Online Figure VIII -step 1). This conclusion was predicted but not proven by earlier studies 19 and is strongly supported by our finding that monocytosis and atherosclerosis are increased in moderately hypercholesterolemic chow-fed mice with deficiency of ABCA1 and ABCG1 in all BM cells, compared with mice with macrophage deficiency of ABCA1/G1 that did not display monocytosis. These findings are also consistent with a recent study in which we used mixed BMT to show that in Apoe −/− mice cell autonomous proliferation and expansion of Apoe −/− HSPCs led to increased monocyte levels and increased entry of Apoe −/− monocytes into atherosclerotic lesions. 33 Overall, these studies show an atheroprotective role for macrophage cholesterol efflux pathways that operate to suppress production of inflammatory cells and inflammatory cytokines and chemokines in lesions. In macrophages, HDL-induced cholesterol efflux decreases foam cell formation and macrophage inflammation, and consequently also the expression of cytokines that instruct the BM to produce monocytes and neutrophils and stimulate monocyte infiltration into atherosclerotic plaques. Consistent with previous studies, 19 our findings indicate that even in the absence of macrophage ABCA1 and ABCG1, marked 2-fold increases in HDL levels derived from a human APOA1 transgene can lead to almost complete suppression of MCP-1, M-CSF, G-CSF, monocytosis, and neutrophilia. Most likely, this reflects the activity of residual cholesterol efflux pathways (Online Figure IIIA) . This suggests that pharmacological interventions that greatly increase HDL production, such as infusions of apoA1 or reconstituted HDL, have strong potential to decrease macrophage inflammatory responses, and suggest that measurements of plasma cytokines, such as MCP-1, M-CSF, G-CSF, or monocyte or neutrophil responses could be a way to monitor the effectiveness of these treatments in humans. 
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